Project description
Connecting doctors and implanted medical devices by synthetic molecular communication
Rising healthcare demand and the prevalence of chronic diseases are driving the growth of active implanted medical devices (AIMDs). However, their placement within the body poses challenges for control and monitoring. In this context, the EIC-funded ERMES project will develop a method for information transfer between doctors and AIMDs using synthetic molecular communication. This approach involves designing molecular messengers and techniques for their injection and modulation within the vascular system. ERMES will establish detection strategies for chemical messengers released by AIMDs. In addition, theoretical models will be developed to optimise communication links, alongside in vitro and in vivo testing to validate and refine the developed concepts.
Objective
The EU defines an active implanted medical device (AIMD) as a device that relies on electrical energy or a source of energy other than that produced directly by the human body or gravity, intended to be implanted, into the human body. The modern demand for medical facilities, the burden of chronic diseases, and technological advancements are the major factors contributing to the growth of the use of AIMDs. The development of AIMD is limited by the restricted possibility of communication to either control or monitor their function being buried inside the body. ERMES project aims to develop a new concept for information transfer between medical doctors (MD) and AIMDs using synthetic molecular communication (MC). MC is a bioinspired communication strategy that involves the use of molecules to encode and transport information. ERMES aims to apply the concept of synthetic MC to enable medical doctors to communicate with future AIMDs. The researcher is going to involve: i) the selection and chemical design and synthesis of the suitable molecular messengers, ii) the design and validation of injection and modulation schemes for molecular messengers propagating in the body's vascular system allowing MD to communicate the desired information towards an AIMD, iii) the development of detection strategies for chemical messengers inside the bloodstream released by the AIMD, and the investigation of suitable concepts to ensure reliable and secure communication between the AIMD and MD. The ERMES will be organized to operate along four Pillars: 1) tools for the theoretical conception, consisting of analytical and simulation models for the design and optimization of all involved communication links, 2) in-vitro experimental systems on a laboratory scale for proofs-of-concept in a controllable environment, 3) in-vivo experimental systems based on models developed ad hoc for studies under real application conditions, 4) Trusted communication between AIMDs.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.1 - The European Innovation Council (EIC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-EIC - HORIZON EIC Grants
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIC-2024-PATHFINDEROPEN-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
95131 Catania
Italy
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.